Stockscreener 앱 받기
6.91
6.47%
0.42
시간 외 거래:
6.72
-0.19
-2.75%
전일 마감가:
$6.49
열려 있는:
$6.35
하루 거래량:
844.06K
Relative Volume:
0.78
시가총액:
$427.90M
수익:
$170.16M
순이익/손실:
$-312.76M
주가수익비율:
-1.2158
EPS:
-5.6837
순현금흐름:
$-178.72M
1주 성능:
+7.97%
1개월 성능:
-28.69%
6개월 성능:
-39.23%
1년 성능:
-7.62%
1일 변동 폭
$6.31
$6.96
1주일 범위
$6.31
$7.10
52주 변동 폭
$5.00
$17.58
깅코 바이오웍스 홀딩스 Stock (DNA) Company Profile
명칭
Ginkgo Bioworks Holdings Inc
전화
(877) 442-5362
주소
27 DRYDOCK AVENUE, BOSTON
Compare DNA vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DNA
Ginkgo Bioworks Holdings Inc
|
6.91 | 401.89M | 170.16M | -312.76M | -178.72M | -5.6837 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
깅코 바이오웍스 홀딩스 Stock (DNA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-05-15 | 다운그레이드 | BTIG Research | Neutral → Sell |
| 2024-05-10 | 다운그레이드 | William Blair | Mkt Perform → Underperform |
| 2023-11-14 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2023-11-09 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2023-06-02 | 다운그레이드 | Goldman | Neutral → Sell |
| 2023-05-11 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2022-11-29 | 개시 | Berenberg | Buy |
| 2022-10-04 | 개시 | Morgan Stanley | Equal-Weight |
| 2022-05-18 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2022-03-02 | 재개 | Cowen | Outperform |
| 2022-02-23 | 개시 | Goldman | Neutral |
| 2022-02-01 | 개시 | BofA Securities | Neutral |
| 2022-01-28 | 개시 | BofA Securities | Buy |
| 2022-01-07 | 개시 | BTIG Research | Buy |
| 2021-11-29 | 개시 | Jefferies | Buy |
| 2021-10-13 | 개시 | Raymond James | Outperform |
| 2021-10-12 | 개시 | William Blair | Outperform |
| 2021-09-20 | 개시 | HSBC Securities | Buy |
모두보기
깅코 바이오웍스 홀딩스 주식(DNA)의 최신 뉴스
Ginkgo Bioworks Holdings, Inc. (DNA) increases despite market slip: Here's what you need to know - MSN
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Sinks As Market Gains: Here's Why - MSN
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q4 2025 earnings call transcript - MSN
EBITDA per share of Ginkgo Bioworks Holdings Inc. – OTC:DNABW - TradingView
Revenue per share of Ginkgo Bioworks Holdings Inc. – OTC:DNABW - TradingView
708 Class A shares notified for sale; prior 972-share sale (DNA) - Stock Titan
Ginkgo Bioworks Announces Date of Third Quarter 2024 Results Pre - GuruFocus
How The Ginkgo Bioworks (DNA) Story Is Shifting As Analysts Revisit Growth And Risk - Yahoo Finance
Ginkgo Bioworks Posts On X "New in @sciam today: Researchers at Ginkgo and @OpenAI showed that an AI model working with an autonomous lab can design and iterate real biology experiments at unprecedented speed. From San Francisco, where GPT-5 - Benzinga
(DNA) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Analysts Conflicted on These Healthcare Names: Valneva (VALN), Biogen (BIIB) and Ginkgo Bioworks Holdings (DNA) - The Globe and Mail
Ginkgo Bioworks (NYSE:DNA) Price Target Cut to $5.00 by Analysts at BTIG Research - MarketBeat
Ginkgo Bioworks price target lowered to $5 from $9 at BTIG - TipRanks
BTIG cuts Ginkgo Bioworks stock price target on autonomous lab shift - Investing.com
Ginkgo Bioworks Holdings Inc (DNA) PT Lowered to $5 at BTIG - StreetInsider
DNA (DNA) Form 144 shows director notices to sell 2,200 shares on two dates - Stock Titan
Risk Hedge: Why is Ginkgo Bioworks Holdings Inc stock going up2026 PreEarnings & Expert Approved Momentum Trade Ideas - baoquankhu1.vn
DNA Technical Analysis | Trend, Signals & Chart Patterns | GINKGO BIOWORKS HOLDINGS INC (NYSE:DNA) - ChartMill
DNA Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Macro Review: Can Ginkgo Bioworks Holdings Inc expand into new marketsInsider Buying & High Win Rate Trade Alerts - baoquankhu1.vn
Elon Musk Endorses 'Fundable' Jurassic Park: These De-Extinction Companies Are Already Making It Happen - Sahm
Ginkgo Bioworks (NYSE:DNA) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Ginkgo Bioworks Bets on Autonomous Labs Amid Headwinds - TipRanks
Weekly Recap: Is Ginkgo Bioworks Holdings Inc attractive for institutional investorsWall Street Watch & Momentum Based Trading Signals - baoquankhu1.vn
DNA Earnings History & Surprises | EPS & Revenue Results | GINKGO BIOWORKS HOLDINGS INC (NYSE:DNA) - ChartMill
Ginkgo Bioworks Holdings, Inc. 2025 Q4ResultsEarnings Call Presentation (NYSE:DNA) 2026-03-03 - Seeking Alpha
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q4 2025 Earnings Call Transcript - Insider Monkey
Ginkgo Bioworks Launches Ginkgo Cloud Lab, Powered by Autonomous Lab Infrastructure - AI Insider
Ginkgo Bioworks Launches Ginkgo Cloud Lab to Provide Remote Access for Researchers - marketscreener.com
Ginkgo Bioworks Makes Major Pivot (NYSE:DNA) - Seeking Alpha
Ginkgo Bioworks Launches Ginkgo Cloud Lab - marketscreener.com
DNA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
A Look At Ginkgo Bioworks (DNA) Valuation As It Pivots To Robotics Labs And Biosecurity Divestiture - Sahm
DNA SEC FilingsGinkgo Bioworks Holdings Inc 10-K, 10-Q, 8-K Forms - Stock Titan
A Look At Ginkgo Bioworks (DNA) Valuation After Earnings Update And Invaio Collaboration - Yahoo Finance
DNABW Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Ginkgo Bioworks Divests Biosecurity Unit, Retains Minority Stake - The Globe and Mail
Ginkgo Bioworks Q4 Earnings Call Highlights - MarketBeat
Ginkgo Bioworks Reports Fourth Quarter and Full Year 2025 Financial Results, Announces Focus on Autonomous Labs Offerings and Divestiture of Its Non-Core Biosecurity Business - 富途牛牛
Analysts Offer Insights on Healthcare Companies: Ginkgo Bioworks Holdings (DNA) and Xenon (XENE) - The Globe and Mail
Ginkgo Bioworks Holdings Inc (DNA) Q4 2025 Earnings Call Highlights: Strategic Shifts and ... By GuruFocus - Investing.com Canada
Ginkgo Bioworks Q4 Loss Profile Reinforces Bearish Narratives On Cash Burn And Profit Timing - simplywall.st
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Ginkgo Bioworks Pivots To AI And Robotics After Rough Quarter - Benzinga
Ginkgo Bioworks Reports Fourth Quarter and Full Year 2025 Financial Results, Announces Focus on Autonomous Labs Offerings and Divestiture of its Non-Core Biosecurity Business - The Malaysian Reserve
Ginkgo Bioworks Holdings, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Ginkgo Bioworks to Sell Biosecurity Unit to Tower Biosecurity, Retaining 20% Equity Stake - TradingView
Ginkgo Bioworks (NYSE: DNA) trades Biosecurity arm for 20% Tower stake - Stock Titan
Ginkgo Bioworks to sell biosecurity unit for 20% stake in Tower Biosecurity - StreetInsider
Ginkgo Bioworks Q4 2025 Earnings Call Transcript - MarketBeat
Erste Asset Management GmbH Acquires 200,000 Shares of Ginkgo Bioworks Holdings, Inc. $DNA - MarketBeat
깅코 바이오웍스 홀딩스 (DNA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.20%
0.06%
자본화:
|
볼륨(24시간):